Goldman Sachs Reinstates Neutral on Kodiak Sciences, Announces $36 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 77.0%

Neg 0% Neu 77% Pos 0%

Goldman Sachs analyst Andrea Newkirk reinstates Kodiak Sciences (NASDAQ:KOD) with a Neutral and announces $36 price target.